Close

Harvard Bioscience (HBIO) Tops Q4 EPS by 1c

February 26, 2015 7:48 AM EST

Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.4 million versus the consensus estimate of $29.3 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings